For the Quarter Ending September 2025
North America
• In United States, the Clindamycin Phosphate Price Index rose quarter-over-quarter in Q3 2025, driven by increased production costs and strong pharmaceutical market sentiment.
• Overall input and raw material costs for chemical manufacturers strengthened in Q3 2025, alongside rising energy expenses.
• The Consumer Price Index increased 3.0% in September 2025, and the Producer Price Index rose 2.6% in August 2025.
• US pharmaceutical market sentiment strengthened in Q3 2025, with national health spending growth accelerating.
• US chemical production levels contracted in Q3 2025, and industry inventories shrank due to accelerating destocking.
• US pharmaceutical product exports strengthened from July to August 2025, while imports weakened.
• Henry Hub natural gas spot prices showed an upward trend towards Q3 2025 end, impacting energy feedstock costs.
• Retail sales grew 5.42% in September 2025, supporting demand, despite consumer confidence declining to 94.2.
Why did the price of Clindamycin Phosphate change in September 2025 in North America?
• Production costs rose due to a 3.0% CPI increase in September 2025 and strengthened raw material expenses.
• Supply tightened as US chemical production contracted in Q3 2025, with industrial production growing only 0.1%.
• Demand was supported by strengthened US pharmaceutical market sentiment and 5.42% retail sales growth in September 2025.
APAC
• In China, the Clindamycin Phosphate Price Index fell quarter-over-quarter in Q3 2025, influenced by a -2.3% PPI year-on-year in September.
• Clindamycin Phosphate production costs faced mixed pressures in Q3 2025, with general input costs rising but industrial electricity rates reduced.
• Clindamycin Phosphate demand was supported by a 6.5% industrial production increase and 3.0% retail sales growth in September.
• Cautious consumer confidence at 89.6 in September 2025 and a -0.3% CPI year-on-year impacted discretionary demand.
• Raw material inventories for manufacturing declined in July 2025, with the rate of decline narrowing by September.
• China's manufacturing sector saw new export orders rise in September 2025, reflecting improved international trade flows.
• Natural gas prices remained stable throughout Q3 2025, providing consistent energy feedstock costs for Clindamycin Phosphate.
• Pharmaceutical market demand increased in Q3 2025, driven by an aging population and rising prevalence of chronic diseases.
Why did the price of Clindamycin Phosphate change in September 2025 in APAC?
• A -2.3% PPI year-on-year in September 2025 reduced factory-gate prices, impacting Clindamycin Phosphate prices.
• Cautious consumer confidence at 89.6 in September 2025 impacted discretionary spending for pharmaceutical products.
• Rising general manufacturing input costs in Q3 2025 exerted upward pressure on Clindamycin Phosphate production expenses.
Europe
• In Germany, the Clindamycin Phosphate Price Index rose quarter-over-quarter in Q3 2025, driven by elevated costs and supply disruptions.
• Clindamycin Phosphate production costs remained high in Q3 2025, influenced by elevated raw material costs and 2.4% CPI in September 2025.
• Despite -1.7% PPI in September 2025, industrial electricity costs remained elevated throughout Q3 2025.
• Clindamycin Phosphate demand was mixed in Q3 2025, with moderate pharmaceutical growth and negative consumer confidence (-23.6, September 2025).
• Industrial production in Germany declined 1.0% year-over-year in September 2025, impacting supply chains.
• Regional supply tightened in Q3 2025 due to unexpected plant disruptions, including a July 2025 fire.
• German chemical sales outside Europe weakened in Q3 2025, while European sales stagnated.
• The Manufacturing Index trend was contracting in September 2025, signaling industrial activity slowdown.
• Natural gas prices fluctuated in Q3 2025, slightly increasing in September compared to August.
Why did the price of Clindamycin Phosphate change in September 2025 in Europe?
• Elevated raw material costs and 2.4% CPI in September 2025 increased production expenses.
• Regional supply tightened in Q3 2025 due to plant disruptions, limiting Clindamycin Phosphate availability.
• Contracting industrial production (-1.0%, September 2025) and negative consumer confidence (-23.6, September 2025) tempered demand.
For the Quarter Ending December 2022
North America
North American region, particularly the USA, witnessed an inclined price trend for Clindamycin Phosphate during the start of October. Increased end-user demand balanced with enough supplies among the market participants kept the prices of Clindamycin Phosphate on the higher side.
Slowing economic activity amid rising borrowing costs, Consumer spending, which edged up 0.1% after surging 0.9% in October, and ease in trade disruption along with shipment cost supported the market sentiments of Clindamycin Phosphate in the USA.
Until November, the cost of Clindamycin Phosphate got settled at USD 146520/MT CFR Los Angeles in the USA. Towards the end of the fourth quarter of 2022, the prices fell significantly, backed by decremented inquiries coupled with the temporary shutdown of the domestic market owing to New-year holidays.
APAC
The prices of Clindamycin Phosphate plummeted at the end of 2022 in the Asia Pacific region, primarily in China. At the start of the fourth quarter, the market of Clindamycin Phosphate visualized a positive market outlook as the demand inclined considerably following the trend of the previous month. Following November, the ease in supply disruption and port congestion at the importing countries additionally supported the price trends of Clindamycin Phosphate and got settled at USD 145255/MT FOB Shanghai. With the start of December, demand in China remains largely dormant, as an outburst of lockdowns of COVID-19 has muted economic output and affected the market sentiments of all the commodities, including Clindamycin Phosphate in China.
Europe
During the fourth quarter of 2022, the European market for Clindamycin Phosphate imitated a similar pattern as that of APAC. The market initially started on a healthy note up to November as the demand from the end-user sector of the pharmaceutical industry increased, which was balanced with the overall supplies among the market participants. After November, the witnesses for the Clindamycin Phosphate pricing were gathered at USD 150640/MT CFR Hamburg. Additionally, in November, the downstream industry started to moderately raise its requests for rates on Clindamycin Phosphate, which helped to keep prices on the higher side. Fresher orders decreased in December of 2022 due to suppliers having high stock levels due to the market's brief closure.
For the Quarter Ending September 2022
North America
The Clindamycin Phosphate market showcased decremented pricing sentiments during the third quarter of 2022 in the North American region. The Clindamycin Phosphate prices in the United States declined throughout the Q3, backed by reduced demand from the downstream pharmaceutical industries amidst weak purchasing activities and overflowing inventories from domestic merchants. Furthermore, the fluctuation in energy values and freight charges also led to the instability in the price of Clindamycin Phosphate. By the termination of the third quarter, the prices of Clindamycin phosphate demonstrated a declined trend with 2.34 percent and got settled at USD 137590/MT CFR Los Angeles.
Asia Pacific
During the third quarter of 2022, Clindamycin Phosphate prices witnessed considerable growth in the APAC region. The price of Clindamycin Phosphate went down poorly in the first and mid of q3, but it then inclined significantly towards the termination of mid of q3. Additionally, supply disruption and higher demand in the market supported the price tendency of Clindamycin Phosphate API in the overall market. Also, trade disruption, cargo shortage, and rerouting activity affected the price of Clindamycin Phosphate in the market, keeping it on the higher side. Furthermore, towards the termination of the third quarter, the prices recorded for Clindamycin Phosphate were settled at USD 135655/MT FOB Shanghai in China.
Europe
The prices of Clindamycin Phosphate in the European region witnessed a declining trend during the q3 of 2022, following the trend of North America. Supply and demand fundamentals witnessed were on the weaker side, resulting in downstream stockpiling with the domestic merchants. Additionally, fluctuations in trade frequency from China during the whole quarter also affected the market value of Clindamycin Phosphate. Also, the slow offtake from downstream pharmaceuticals was one of the factors behind this weak price trend of Clindamycin Phosphate in Germany. Thus, with the end of q3, the prices of Clindamycin Phosphate settled at USD 145280/MT CFR Hamburg.
For the Quarter Ending June 2022
North America
North American market witnessed a continual rise in the prices of Clindamycin Phosphate API during the second Quarter of 2022, backed by enhanced downstream demand from various pharmaceutical and biopharmaceutical sectors. Besides that, rerouting activities and import facilities leading to delayed shipments in the international market affected the prices of Clindamycin phosphate. Also, the gradual increase in feedstock cost from various importing countries resulted in the price enhancement of downstream Clindamycin Phosphate API in the market. Additionally, insufficient stocks with the traders caused heightened production activities with surging demand, which in turn was another factor that led to API's price increment..With the termination of second quarter the prices recorded for Clindamycin Phosphate were settled at USD 146820/MT with an average inclination of 2.34 percent in US.
Asia Pacific
During the Second Quarter, the Clindamycin Phosphate market witnessed significant growth in the APAC region. The price of Clindamycin Phosphate went high because the demand side exceeded the market's supply side. urther, higher upstream feed prices caused the cost to spike high of downstream clindamycin phosphate in the regional and domestic markets. In addition, supply disruption and labor shortage due to higher demand in the market added another reason for the price enhancement of API in the market. Also, trade disruption, cargo shortage, and rerouting activity affected the price value of Clindamycin Phosphate in the market.Towards the termination of second quarter the prices recorded for Clindamycin Phosphate were settled at USD 135820/MT FOB Shanghai in China.
Europe
During the Second Quarter of 2022, the European region showcased a similar market sentiment for Clindamycin Phosphate to the North American region. An increase in downstream demand from various pharmaceutical sectors was one of the important factors that drove Clindamycin Phosphate API price value in the market. Furthermore, the prices went high significantly as China being the major exporter of API, increasing covid cases resulted in a temporary shutdown of manufacturing units in Shanghai and Beijing, affecting the trading activities, which in turn affected the prices of Clindamycin Phosphate all over the region. Additionally, higher freight charges, owing to the shortage of cargo, affected the cost of Clindamycin Phosphate further. Towards the termination of second quarter the prices recorded for Clindamycin Phosphate were settled at USD 154820/MT CFR Hamburgin Germany.
